Trials / Conditions / Acute Promyelocytic Leukemia (APL)

Acute Promyelocytic Leukemia (APL)

8 registered clinical trials studyying Acute Promyelocytic Leukemia (APL) — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia NCT07504458	Quetzal Therapeutics	Phase 3
Not Yet Recruiting	A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokin NCT07296445	SDK Therapeutics, Inc.	Phase 3
Completed	AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Cli NCT07203885	Harvard Medical School (HMS and HSDM)	N/A
Active Not Recruiting	Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia NCT07187505	Anhui Medical University	N/A
Completed	Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare I NCT06882031	SDK Therapeutics, Inc.	Phase 1
Recruiting	Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia NCT06982274	Instituto do Cancer do Estado de São Paulo	Phase 2
Completed	Red Cell Transfusion Goals in Patients With Acute Leukemias NCT02086773	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1
Terminated	Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler NCT01463410	Skyline Diagnostics BV	—